Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease-Are Current Screening Strategies Adequate?

J Crohns Colitis. 2017 Jun 1;11(6):762-763. doi: 10.1093/ecco-jcc/jjw204.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / administration & dosage
  • Adalimumab / adverse effects*
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Antitubercular Agents / administration & dosage*
  • Ascites* / diagnostic imaging
  • Ascites* / etiology
  • Ascites* / microbiology
  • Colon / diagnostic imaging
  • Colon / pathology
  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Latent Tuberculosis* / complications
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Latent Tuberculosis* / physiopathology
  • Mass Screening / methods
  • Middle Aged
  • Mycobacterium tuberculosis* / isolation & purification
  • Mycobacterium tuberculosis* / physiology
  • Radiography, Abdominal / methods
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab